Interest Expense, Nonoperating

Name: Ligand Pharmaceuticals Interest Expense, Nonoperating by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Ligand Pharmaceuticals·Business Segments·1 segment·Rolls up to Interest Expense

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	$867K	$1.15M	$910K	$1.79M	$1.75M
Total	$867K	$1.15M	$910K	$1.79M	$1.75M

Segments

Business SegmentsView metric